rs150692845

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_000719.7(CACNA1C):​c.1734G>A​(p.Leu578Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000639 in 1,612,064 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. L578L) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000046 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000066 ( 0 hom. )

Consequence

CACNA1C
NM_000719.7 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.0670

Publications

0 publications found
Variant links:
Genes affected
CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]
CACNA1C Gene-Disease associations (from GenCC):
  • Timothy syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, G2P, Labcorp Genetics (formerly Invitae)
  • neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics
  • long QT syndrome
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • long QT syndrome 8
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • Brugada syndrome
    Inheritance: AD Classification: SUPPORTIVE, NO_KNOWN Submitted by: Orphanet, ClinGen
  • Brugada syndrome 3
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • intellectual disability
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • short QT syndrome
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.44).
BP6
Variant 12-2567633-G-A is Benign according to our data. Variant chr12-2567633-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 308136.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.067 with no splicing effect.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.000046 (7/152330) while in subpopulation EAS AF = 0.00135 (7/5178). AF 95% confidence interval is 0.000634. There are 0 homozygotes in GnomAd4. There are 2 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 7 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1CNM_000719.7 linkc.1734G>A p.Leu578Leu synonymous_variant Exon 13 of 47 ENST00000399655.6 NP_000710.5 Q13936-12
CACNA1CNM_001167623.2 linkc.1734G>A p.Leu578Leu synonymous_variant Exon 13 of 47 ENST00000399603.6 NP_001161095.1 Q13936-37

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1CENST00000399603.6 linkc.1734G>A p.Leu578Leu synonymous_variant Exon 13 of 47 5 NM_001167623.2 ENSP00000382512.1 Q13936-37
CACNA1CENST00000399655.6 linkc.1734G>A p.Leu578Leu synonymous_variant Exon 13 of 47 1 NM_000719.7 ENSP00000382563.1 Q13936-12
CACNA1CENST00000682544.1 linkc.1824G>A p.Leu608Leu synonymous_variant Exon 13 of 50 ENSP00000507184.1 A0A804HIR0
CACNA1CENST00000406454.8 linkc.1734G>A p.Leu578Leu synonymous_variant Exon 13 of 48 5 ENSP00000385896.3 F5GY28
CACNA1CENST00000399634.6 linkc.1734G>A p.Leu578Leu synonymous_variant Exon 13 of 47 5 ENSP00000382542.2 E9PDI6
CACNA1CENST00000683824.1 linkc.1899G>A p.Leu633Leu synonymous_variant Exon 14 of 48 ENSP00000507867.1 A0A804HKC4
CACNA1CENST00000347598.9 linkc.1734G>A p.Leu578Leu synonymous_variant Exon 13 of 49 1 ENSP00000266376.6 Q13936-11
CACNA1CENST00000344100.7 linkc.1734G>A p.Leu578Leu synonymous_variant Exon 13 of 47 1 ENSP00000341092.3 Q13936-14
CACNA1CENST00000327702.12 linkc.1734G>A p.Leu578Leu synonymous_variant Exon 13 of 48 1 ENSP00000329877.7 A0A0A0MR67
CACNA1CENST00000399617.6 linkc.1734G>A p.Leu578Leu synonymous_variant Exon 13 of 48 5 ENSP00000382526.1 A0A0A0MSA1
CACNA1CENST00000682462.1 linkc.1824G>A p.Leu608Leu synonymous_variant Exon 13 of 47 ENSP00000507105.1 A0A804HIJ8
CACNA1CENST00000683781.1 linkc.1824G>A p.Leu608Leu synonymous_variant Exon 13 of 47 ENSP00000507434.1 A0A804HJB6
CACNA1CENST00000683840.1 linkc.1824G>A p.Leu608Leu synonymous_variant Exon 13 of 47 ENSP00000507612.1 A0A804HJR1
CACNA1CENST00000683956.1 linkc.1824G>A p.Leu608Leu synonymous_variant Exon 13 of 47 ENSP00000506882.1 A0A804HI37
CACNA1CENST00000399638.5 linkc.1734G>A p.Leu578Leu synonymous_variant Exon 13 of 48 1 ENSP00000382547.1 Q13936-31
CACNA1CENST00000335762.10 linkc.1809G>A p.Leu603Leu synonymous_variant Exon 14 of 48 5 ENSP00000336982.5 F5H522
CACNA1CENST00000399606.5 linkc.1734G>A p.Leu578Leu synonymous_variant Exon 13 of 48 1 ENSP00000382515.1 Q13936-30
CACNA1CENST00000399621.5 linkc.1734G>A p.Leu578Leu synonymous_variant Exon 13 of 47 1 ENSP00000382530.1 Q13936-24
CACNA1CENST00000399637.5 linkc.1734G>A p.Leu578Leu synonymous_variant Exon 13 of 47 1 ENSP00000382546.1 Q13936-27
CACNA1CENST00000402845.7 linkc.1734G>A p.Leu578Leu synonymous_variant Exon 13 of 47 1 ENSP00000385724.3 Q13936-13
CACNA1CENST00000399629.5 linkc.1734G>A p.Leu578Leu synonymous_variant Exon 13 of 47 1 ENSP00000382537.1 Q13936-32
CACNA1CENST00000682336.1 linkc.1809G>A p.Leu603Leu synonymous_variant Exon 14 of 47 ENSP00000507898.1 A0A804HKE9
CACNA1CENST00000399591.5 linkc.1734G>A p.Leu578Leu synonymous_variant Exon 13 of 46 1 ENSP00000382500.1 Q13936-29
CACNA1CENST00000399595.5 linkc.1734G>A p.Leu578Leu synonymous_variant Exon 13 of 46 1 ENSP00000382504.1 Q13936-25
CACNA1CENST00000399649.5 linkc.1734G>A p.Leu578Leu synonymous_variant Exon 13 of 46 1 ENSP00000382557.1 Q13936-15
CACNA1CENST00000399597.5 linkc.1734G>A p.Leu578Leu synonymous_variant Exon 13 of 47 1 ENSP00000382506.1 Q13936-22
CACNA1CENST00000399601.5 linkc.1734G>A p.Leu578Leu synonymous_variant Exon 13 of 47 1 ENSP00000382510.1 Q13936-20
CACNA1CENST00000399641.6 linkc.1734G>A p.Leu578Leu synonymous_variant Exon 13 of 47 1 ENSP00000382549.1 Q13936-23
CACNA1CENST00000399644.5 linkc.1734G>A p.Leu578Leu synonymous_variant Exon 13 of 47 1 ENSP00000382552.1 Q13936-21
CACNA1CENST00000682835.1 linkc.1734G>A p.Leu578Leu synonymous_variant Exon 13 of 47 ENSP00000507282.1 A0A804HIZ0
CACNA1CENST00000683482.1 linkc.1725G>A p.Leu575Leu synonymous_variant Exon 13 of 47 ENSP00000507169.1 Q13936-35
CACNA1CENST00000682686.1 linkc.1734G>A p.Leu578Leu synonymous_variant Exon 13 of 46 ENSP00000507309.1 Q13936-19
CACNA1CENST00000480911.6 linkn.*341G>A non_coding_transcript_exon_variant Exon 11 of 27 5 ENSP00000437936.2 F5H638
CACNA1CENST00000480911.6 linkn.*341G>A 3_prime_UTR_variant Exon 11 of 27 5 ENSP00000437936.2 F5H638

Frequencies

GnomAD3 genomes
AF:
0.0000460
AC:
7
AN:
152212
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00135
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000940
AC:
23
AN:
244584
AF XY:
0.0000678
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00123
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000167
GnomAD4 exome
AF:
0.0000658
AC:
96
AN:
1459734
Hom.:
0
Cov.:
31
AF XY:
0.0000744
AC XY:
54
AN XY:
725890
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33448
American (AMR)
AF:
0.00
AC:
0
AN:
44494
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26058
East Asian (EAS)
AF:
0.00232
AC:
92
AN:
39646
South Asian (SAS)
AF:
0.0000117
AC:
1
AN:
85658
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53248
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5764
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1111100
Other (OTH)
AF:
0.0000497
AC:
3
AN:
60318
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
5
11
16
22
27
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000460
AC:
7
AN:
152330
Hom.:
0
Cov.:
32
AF XY:
0.0000269
AC XY:
2
AN XY:
74478
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41586
American (AMR)
AF:
0.00
AC:
0
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00135
AC:
7
AN:
5178
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68028
Other (OTH)
AF:
0.00
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.554
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000378
Asia WGS
AF:
0.000866
AC:
3
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Long QT syndrome Benign:1
May 21, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiovascular phenotype Benign:1
May 26, 2017
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.44
CADD
Benign
6.9
DANN
Benign
0.81
PhyloP100
0.067

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs150692845; hg19: chr12-2676799; API